*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Atlanta, GA | Posted: September 8, 2021
Communications
Wallace H. Coulter Department of Biomedical Engineering
Summary Sentence:
Karmella Haynes will help advise the government on oversight of biological research that could prove harmful if misused
Full Summary:
Karmella Haynes will help advise the government on oversight of biological research that could prove harmful if misused.
Karmella Haynes, Ph.D. (vertical)The National Institutes of Health has invited Karmella Haynes to help advise the government on oversight of biological research that could be misused.
Haynes is joining the National Science Advisory Board for Biosecurity, a federal advisory committee chartered to provide “advice, guidance, and leadership” for what the U.S. government terms dual-use research — in other words, research with legitimate and important scientific purpose that could also yield technologies or information that could prove harmful if misused. Haynes will serve a three-year term.
“While I don't deeply investigate biocontainment in my own research, I care about it and have spoken up about it because I care about the broader, real human impact of biotechnology,” said Haynes, an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.
Haynes has been involved in biosafety and biocontainment issues for several years, previously serving on an advisory panel on the topic for the L. Craig Venter Institute and actively reviewing grants in the area for the Joint Genome Engineering Institute. She also has spoken to Congress about synthetic biology and been invited to international conversations about synthetic biology.
“I hope to offer a lucid perspective on what we should be concerned about versus what people are suspicious or scared of,” Haynes said, “and to remind policymakers that the greatest enemy is uncertainty, not necessarily the biotech. The greatest solution to uncertainty is proactive science, not moratoriums.”
As a member of the advisory board, Haynes will help develop recommendations for proper oversight of federally conducted dual-use biological research, balancing the needs of the research community with national security concerns.
